1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics. CA Cancer J Clin. 63:11–30. 2013.
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
3
|
Quinn BA, Xiao F, Bickel L, Martin L, Hua
X, et al: Development of a syngeneic mouse model of epithelial
ovarian cancer. J Ovarian Res. 3:242010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Mullany LK and Richards JS: Minireview:
animal models and mechanisms of ovarian cancer development.
Endocrinology. 153:1585–1592. 2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Zhang J, Chen X, Shi G, Xie X, Liu H, et
al: Establishment of a new representative model of human ovarian
cancer in mice. J Ovarian Res. 6:92013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Sloan Stakleff KD, Rouse AG, Ryan AP,
Haller NA and Von Gruenigen VE: A novel early-stage orthotopic
model for ovarian cancer in the Fischer 344 rat. Int J Gynecol
Cancer. 15:246–254. 2005.PubMed/NCBI
|
7
|
Fong MY and Kakar SS: Ovarian cancer mouse
models, a summary of current models and their limitations. J
Ovarian Res. 2:122009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Garson K, Gamwell LF, Pitre EM and
Vanderhyden BC: Technical challenges and limitations of current
mouse models of ovarian cancer. J Ovarian Res. 5:392012. View Article : Google Scholar : PubMed/NCBI
|
9
|
Allen M and Louise Jones J: Jekyll and
Hyde: the role of the microenvironment on the progression of
cancer. J Pathol. 223:162–176. 2011. View Article : Google Scholar : PubMed/NCBI
|
10
|
Balkwill FR, Capasso M and Hagemann T: The
tumor microenvironment at a glance. J Cell Sci. 125:5591–5596.
2012. View Article : Google Scholar : PubMed/NCBI
|
11
|
Shultz LD, Ishikawa F and Greiner DL:
Humanized mice in translational biomedical research. Nat Rev
Immunol. 7:118–130. 2007. View
Article : Google Scholar : PubMed/NCBI
|
12
|
Bankert RB, Egilmez NK and Hess SD:
Human-SCID mouse chimeric models for the evaluation of anti-cancer
therapies. Trends Immunol. 22:386–393. 2001. View Article : Google Scholar : PubMed/NCBI
|
13
|
Proia DA and Kuperwasser C: Reconstruction
of human mammary tissues in a mouse model. Nat Protoc. 1:206–214.
2006. View Article : Google Scholar : PubMed/NCBI
|
14
|
Bankert RB, Balu-Iyer SV, Odunsi K, Shultz
LD, Kelleher RJ Jr, et al: Humanized mouse model of ovarian cancer
recapitulates patient solid tumor progression, ascites formation,
and metastasis. PLoS One. 6:e244202011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Wang J, Xia TS, Liu XA, Ding Q, Du Q, et
al: A novel orthotopic and metastatic mouse model of breast cancer
in human mammary microenvironment. Breast Cancer Res Treat.
120:337–344. 2010. View Article : Google Scholar : PubMed/NCBI
|
16
|
Zheng MJ, Wang J, Chen YW, Xu L, Xue DD,
et al: A novel mouse model of gastric cancer with human gastric
microenvironment. Cancer Lett. 325:108–115. 2012. View Article : Google Scholar : PubMed/NCBI
|
17
|
Priolo C, Agostini M, Vena N, Ligon AH,
Fiorentino M, et al: Establishment and genomic characterization of
mouse xenografts of human primary prostate tumors. Am J Pathol.
176:1901–1913. 2010. View Article : Google Scholar : PubMed/NCBI
|
18
|
Weinberg RA: Coevolution in the tumor
microenvironment. Nat Genet. 40:494–495. 2008. View Article : Google Scholar : PubMed/NCBI
|
19
|
Pietras K and Ostman A: Hallmarks of
cancer: interactions with the tumor stroma. Exp Cell Res.
316:1324–1331. 2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Mueller MM and Fusenig NE: Friends or foes
- bipolar effects of the tumour stroma in cancer. Nat Rev Cancer.
4:839–849. 2004. View
Article : Google Scholar : PubMed/NCBI
|
21
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar
|
22
|
Weis SM and Cheresh DA: Tumor
angiogenesis: molecular pathways and therapeutic targets. Nat Med.
17:1359–1370. 2011. View
Article : Google Scholar : PubMed/NCBI
|